Mayo Clinic Laboratory and Pathology Research Roundup: March 20 - Insights
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Mayo Clinic Laboratory and Pathology Research Roundup: May 1 - Insights
This week’s Research Roundup highlights the association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 8 - Insights
This week’s Research Roundup highlights how cardiac troponin is released from injured myocardium.
Mayo Clinic Laboratory and pathology research roundup: January 10 - Insights
This week's research roundup features: Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
A Test in Focus Archives - Page 6 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Skip to Content MayoACCESS MayoLINK...
Saving and improving lives: The illuminating journey of a laboratory testing specimen - Insights
Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on...
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...